Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit)

v3.24.1.1.u2
Unaudited Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Preferred Stock [Member]
Preferred Class A [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2022 250,000 63,671        
Balance at Dec. 31, 2022 $ 0 $ 0 $ 84,456 $ (80,551) $ (639) $ 3,266
Share based compensation (in shares) 0 0        
Share based compensation $ 0 $ 0 11 0 0 11
Issuance of common stock to Fortress (in shares) 0 4,997        
Issuance of common stock to Fortress $ 0 $ 0 72 0 0 72
Exercise of warrants (in shares) 0 5,335        
Exercise of warrants $ 0 $ 0 0 0 0 0
Net loss attributable to non-controlling interests 0 0 0 0 (66) (66)
Net loss attributable to common stockholders $ 0 $ 0 0 (7,536) 0 (7,536)
Balance (in shares) at Mar. 31, 2023 250,000 91,066        
Balance at Mar. 31, 2023 $ 0 $ 0 86,635 (88,087) (705) (2,157)
Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement (in shares) 0 5,974        
Issuance of common stock and pre-funded warrants, net of offering costs - registered direct offering and private placement $ 0 $ 0 865 0 0 865
Issuance of common stock for license acquisition (in shares) 0 11,089        
Issuance of common stock for license acquisition $ 0 $ 0 1,231 0 0 1,231
Balance (in shares) at Dec. 31, 2023 250,000 341,324        
Balance at Dec. 31, 2023 $ 0 $ 3 92,507 (90,928) (928) 654
Share based compensation (in shares) 0 283        
Share based compensation $ 0 $ 0 191 0 0 191
Common shares issuable - Founders Agreement $ 0 $ 0 (363) 0 0 (363)
Issuance of common stock to Fortress (in shares) 0 28,019        
Issuance of common stock to Fortress $ 0 $ 0 371 0 0 371
Loss on settlement of common stock warrant liabilities $ 0 $ 0 574 0 0 574
Exercise of warrants (in shares) 0 220,538        
Exercise of warrants $ 0 $ 1 5,261 0 0 5,262
Warrant inducement offering costs $ 0 $ 0 (442) 0 0 (442)
Reverse split (1-for-75) (in shares) 24        
Reverse split (1-for-75) $ (4) 4 0 0 0
Non-controlling interest in subsidiaries 0 0 1 0 (1) 0
Net loss attributable to non-controlling interests 0 0 0 0 (9) (9)
Net loss attributable to common stockholders $ 0 $ 0 0 (4,340) 0 (4,340)
Balance (in shares) at Mar. 31, 2024 250,000 590,188        
Balance at Mar. 31, 2024 $ 0 $ 0 $ 98,104 $ (95,268) $ (938) $ 1,898